| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | host cellular component | 1.01e-04 | 15 | 130 | 3 | GO:0018995 | |
| GeneOntologyCellularComponent | host intracellular region | 5.66e-04 | 6 | 130 | 2 | GO:0043656 | |
| GeneOntologyCellularComponent | host cell cytoplasm | 5.66e-04 | 6 | 130 | 2 | GO:0030430 | |
| GeneOntologyCellularComponent | host cell part | 5.66e-04 | 6 | 130 | 2 | GO:0033643 | |
| GeneOntologyCellularComponent | host intracellular part | 5.66e-04 | 6 | 130 | 2 | GO:0033646 | |
| GeneOntologyCellularComponent | host cell cytoplasm part | 5.66e-04 | 6 | 130 | 2 | GO:0033655 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole | 5.66e-04 | 6 | 130 | 2 | GO:0020003 | |
| GeneOntologyCellularComponent | symbiont-containing vacuole membrane | 5.66e-04 | 6 | 130 | 2 | GO:0020005 | |
| MousePheno | neuron degeneration | RPGRIP1 CIB2 ATP6AP1 UBE4B APAF1 CCDC66 LOXHD1 SACS MACF1 RORB RP1 MTCL1 HERC2 | 8.81e-06 | 391 | 107 | 13 | MP:0003224 |
| Domain | PH | ARHGEF19 PSD2 RASGRF2 CYTH1 ARHGAP26 KIF1B SPTBN1 MCF2 ASAP1 ARHGEF6 | 3.07e-05 | 278 | 133 | 10 | SM00233 |
| Domain | PH_DOMAIN | ARHGEF19 PSD2 RASGRF2 CYTH1 ARHGAP26 KIF1B SPTBN1 MCF2 ASAP1 ARHGEF6 | 3.16e-05 | 279 | 133 | 10 | PS50003 |
| Domain | PH_domain | ARHGEF19 PSD2 RASGRF2 CYTH1 ARHGAP26 KIF1B SPTBN1 MCF2 ASAP1 ARHGEF6 | 3.26e-05 | 280 | 133 | 10 | IPR001849 |
| Domain | PH | 3.90e-05 | 229 | 133 | 9 | PF00169 | |
| Domain | Spectrin_repeat | 5.08e-05 | 29 | 133 | 4 | IPR002017 | |
| Domain | SPEC | 7.57e-05 | 32 | 133 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.57e-05 | 32 | 133 | 4 | IPR018159 | |
| Domain | CH | 9.96e-05 | 65 | 133 | 5 | SM00033 | |
| Domain | - | ARHGEF19 PSD2 RASGRF2 CYTH1 ARHGAP26 KIF1B SPTBN1 MCF2 ASAP1 FRMD4A ARHGEF6 | 1.13e-04 | 391 | 133 | 11 | 2.30.29.30 |
| Domain | CH | 1.42e-04 | 70 | 133 | 5 | PF00307 | |
| Domain | - | 1.52e-04 | 71 | 133 | 5 | 1.10.418.10 | |
| Domain | CH | 1.73e-04 | 73 | 133 | 5 | PS50021 | |
| Domain | CH-domain | 1.97e-04 | 75 | 133 | 5 | IPR001715 | |
| Domain | PH_dom-like | ARHGEF19 PSD2 RASGRF2 CYTH1 ARHGAP26 KIF1B SPTBN1 MCF2 ASAP1 FRMD4A ARHGEF6 | 2.38e-04 | 426 | 133 | 11 | IPR011993 |
| Domain | Mib_Herc2 | 2.99e-04 | 4 | 133 | 2 | IPR010606 | |
| Domain | MIB_HERC2 | 2.99e-04 | 4 | 133 | 2 | PS51416 | |
| Domain | MIB_HERC2 | 2.99e-04 | 4 | 133 | 2 | PF06701 | |
| Domain | TSP_3 | 4.96e-04 | 5 | 133 | 2 | PF02412 | |
| Domain | TSP3 | 4.96e-04 | 5 | 133 | 2 | PS51234 | |
| Domain | TSP_CTER | 4.96e-04 | 5 | 133 | 2 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 4.96e-04 | 5 | 133 | 2 | IPR017897 | |
| Domain | TSP_type-3_rpt | 4.96e-04 | 5 | 133 | 2 | IPR028974 | |
| Domain | - | 4.96e-04 | 5 | 133 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 4.96e-04 | 5 | 133 | 2 | IPR008859 | |
| Domain | TSP_C | 4.96e-04 | 5 | 133 | 2 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 4.96e-04 | 5 | 133 | 2 | IPR003367 | |
| Domain | Spectrin | 5.63e-04 | 23 | 133 | 3 | PF00435 | |
| Domain | ACTININ_2 | 5.63e-04 | 23 | 133 | 3 | PS00020 | |
| Domain | ACTININ_1 | 5.63e-04 | 23 | 133 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.63e-04 | 23 | 133 | 3 | IPR001589 | |
| Domain | HECT | 9.11e-04 | 27 | 133 | 3 | PF00632 | |
| Domain | HECTc | 9.11e-04 | 27 | 133 | 3 | SM00119 | |
| Domain | HECT_dom | 9.11e-04 | 27 | 133 | 3 | IPR000569 | |
| Domain | HECT | 9.11e-04 | 27 | 133 | 3 | PS50237 | |
| Domain | DH_1 | 1.06e-03 | 63 | 133 | 4 | PS00741 | |
| Domain | RhoGEF | 1.41e-03 | 68 | 133 | 4 | SM00325 | |
| Domain | RhoGEF | 1.57e-03 | 70 | 133 | 4 | PF00621 | |
| Domain | DH_2 | 1.57e-03 | 70 | 133 | 4 | PS50010 | |
| Domain | - | 1.65e-03 | 71 | 133 | 4 | 1.20.900.10 | |
| Domain | DH-domain | 1.65e-03 | 71 | 133 | 4 | IPR000219 | |
| Domain | PH_dom-spectrin-type | 1.75e-03 | 9 | 133 | 2 | IPR001605 | |
| Domain | GBP_C | 2.18e-03 | 10 | 133 | 2 | PF02841 | |
| Domain | U2A'_phosphoprotein32A_C | 2.65e-03 | 11 | 133 | 2 | IPR003603 | |
| Domain | G_GB1_RHD3_dom | 2.65e-03 | 11 | 133 | 2 | IPR030386 | |
| Domain | Guanylate-bd_N | 2.65e-03 | 11 | 133 | 2 | IPR015894 | |
| Domain | PNMA | 2.65e-03 | 11 | 133 | 2 | IPR026523 | |
| Domain | LRRcap | 2.65e-03 | 11 | 133 | 2 | SM00446 | |
| Domain | Guanylate-bd_C | 2.65e-03 | 11 | 133 | 2 | IPR003191 | |
| Domain | GBP | 2.65e-03 | 11 | 133 | 2 | PF02263 | |
| Domain | PNMA | 2.65e-03 | 11 | 133 | 2 | PF14893 | |
| Domain | G_GB1_RHD3 | 2.65e-03 | 11 | 133 | 2 | PS51715 | |
| Domain | EF-hand_7 | 3.19e-03 | 85 | 133 | 4 | PF13499 | |
| Domain | I-BAR_dom | 3.73e-03 | 13 | 133 | 2 | IPR013606 | |
| Domain | Znf_FYVE_PHD | 4.05e-03 | 147 | 133 | 5 | IPR011011 | |
| Domain | SH3 | 4.53e-03 | 216 | 133 | 6 | PS50002 | |
| Domain | SH3_domain | 4.95e-03 | 220 | 133 | 6 | IPR001452 | |
| Domain | - | 4.97e-03 | 15 | 133 | 2 | 1.10.1000.11 | |
| Domain | Sec7 | 4.97e-03 | 15 | 133 | 2 | PF01369 | |
| Domain | Sec7_alpha_orthog | 4.97e-03 | 15 | 133 | 2 | IPR023394 | |
| Domain | SEC7 | 5.66e-03 | 16 | 133 | 2 | PS50190 | |
| Domain | AT_hook | 5.66e-03 | 16 | 133 | 2 | PF02178 | |
| Domain | Sec7 | 5.66e-03 | 16 | 133 | 2 | SM00222 | |
| Domain | Sec7_dom | 5.66e-03 | 16 | 133 | 2 | IPR000904 | |
| Domain | SH3_1 | 6.41e-03 | 164 | 133 | 5 | PF00018 | |
| Pubmed | EHBP1 SYNE1 SPTBN1 MYO18A KPNA6 NCL YWHAH ASAP1 TOX4 KRT20 MACF1 HERC2 COG4 PYGO1 | 9.77e-09 | 486 | 138 | 14 | 20936779 | |
| Pubmed | KPNA6 is a Cofactor of ANP32A/B in Supporting Influenza Virus Polymerase Activity. | 6.11e-08 | 3 | 138 | 3 | 35044222 | |
| Pubmed | 6.11e-08 | 3 | 138 | 3 | 20676096 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | EHBP1 KDM5B OFD1 KIF1B SPTBN1 RIPK2 MAP3K6 YWHAH FSIP2 SYDE2 CCDC138 MACF1 MTCL1 HECTD1 SMAP2 TRAPPC9 CCDC102A | 6.18e-08 | 861 | 138 | 17 | 36931259 |
| Pubmed | Delineation of mRNA export pathways by the use of cell-permeable peptides. | 2.44e-07 | 4 | 138 | 3 | 11729309 | |
| Pubmed | EXOSC10 ATP6AP1 OFD1 ANP32B SYNE1 AHCTF1 SPTBN1 APAF1 MYO18A NCL RB1CC1 PGD GTF3C3 SLC6A8 SACS BAZ2A CCDC138 MACF1 HERC2 ESPL1 SMAP2 | 4.42e-07 | 1487 | 138 | 21 | 33957083 | |
| Pubmed | ZFYVE16 UBE4B SYNE1 KIF1B RNF157 ASAP1 BAZ2A GCC2 MACF1 MTCL1 SENP7 | 7.51e-07 | 407 | 138 | 11 | 12693553 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EXOSC10 CASP14 UBE4B SMCHD1 AHCTF1 POLR2A SPTBN1 NCL PGD GTF3C3 ASAP1 HIRA ZC2HC1A BAZ2A MACF1 PRR14L LTF HERC2 LYZ | 1.80e-06 | 1353 | 138 | 19 | 29467282 |
| Pubmed | WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation. | 2.05e-06 | 52 | 138 | 5 | 30655611 | |
| Pubmed | EXOSC10 SMCHD1 AHCTF1 POLR2A SPTBN1 NCL GTF3C3 BAZ2A PREP MACF1 LTF HERC2 HECTD1 | 2.21e-06 | 653 | 138 | 13 | 22586326 | |
| Pubmed | KDM5B UBE4B TNPO2 SYNE1 CYTH1 KIF1B SPTBN1 KPNA6 YWHAH FRY SACS KCNQ2 MACF1 RORB SMPD3 HERC2 HECTD1 COG4 | 3.57e-06 | 1285 | 138 | 18 | 35914814 | |
| Pubmed | 3.88e-06 | 27 | 138 | 4 | 19026994 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KDM5B EXOSC10 SYNE1 CYTH1 POLR2A SPTBN1 MYO18A NCL GTF3C3 HIRA LHX2 ZC2HC1A SACS MACF1 COG4 ARHGEF6 | 6.63e-06 | 1082 | 138 | 16 | 38697112 |
| Pubmed | EHBP1 KDM5B ZFYVE16 LIN54 RB1CC1 GTF3C3 TOX4 GCC2 KIAA1958 ZFHX3 | 7.12e-06 | 418 | 138 | 10 | 34709266 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ARHGEF19 OFD1 SEMA7A UBE4B CYTH1 ARHGAP26 POLR2A UBE3B FYCO1 HIRA SLC6A8 KCNQ2 HERC2 ESPL1 HECTD1 TRAPPC9 | 8.61e-06 | 1105 | 138 | 16 | 35748872 |
| Pubmed | Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. | 9.85e-06 | 11 | 138 | 3 | 24715728 | |
| Pubmed | CASP14 OFD1 TNPO2 SMCHD1 LIN54 SPTBN1 MYO18A YWHAH GTF3C3 HIRA LHX2 CCDC138 ZFHX3 GNB4 HERC2 SMAP2 TRAPPC9 PYGO1 | 1.51e-05 | 1429 | 138 | 18 | 35140242 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 21142871 | ||
| Pubmed | Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells. | 1.56e-05 | 2 | 138 | 2 | 22751466 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 24340941 | ||
| Pubmed | Associations of THBS2 and THBS4 polymorphisms to gastric cancer in a Southeast Chinese population. | 1.56e-05 | 2 | 138 | 2 | 27160021 | |
| Pubmed | Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. | 1.56e-05 | 2 | 138 | 2 | 21900205 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 37621179 | ||
| Pubmed | Increased cortical expression of two synaptogenic thrombospondins in human brain evolution. | 1.56e-05 | 2 | 138 | 2 | 17182969 | |
| Pubmed | Greatwall is essential to prevent mitotic collapse after nuclear envelope breakdown in mammals. | 1.56e-05 | 2 | 138 | 2 | 24101512 | |
| Pubmed | Generation of bi-transgenic pigs overexpressing human lactoferrin and lysozyme in milk. | 1.56e-05 | 2 | 138 | 2 | 25236863 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 31399282 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19563039 | ||
| Pubmed | Biophysical characterization of the signature domains of thrombospondin-4 and thrombospondin-2. | 1.56e-05 | 2 | 138 | 2 | 16246837 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 30996088 | ||
| Pubmed | Species specific differences in use of ANP32 proteins by influenza A virus. | 1.56e-05 | 2 | 138 | 2 | 31159925 | |
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 27165042 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 19435495 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9359845 | ||
| Pubmed | 1.56e-05 | 2 | 138 | 2 | 9659399 | ||
| Pubmed | 2.69e-05 | 15 | 138 | 3 | 29056340 | ||
| Pubmed | SYNE1 CYTH1 SPTBN1 RIPK2 FYCO1 NCL YWHAH HIRA FRY KCNA2 ZC2HC1A MACF1 MTCL1 HERC2 | 3.11e-05 | 963 | 138 | 14 | 28671696 | |
| Pubmed | 3.99e-05 | 17 | 138 | 3 | 10931824 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 15121769 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 23460613 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 25916827 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 25976449 | ||
| Pubmed | Loss of KCNQ2 or KCNQ3 Leads to Multifocal Time-Varying Activity in the Neonatal Forebrain Ex Vivo. | 4.68e-05 | 3 | 138 | 2 | 33863780 | |
| Pubmed | Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. | 4.68e-05 | 3 | 138 | 2 | 12522243 | |
| Pubmed | Interaction of tear lipocalin with lysozyme and lactoferrin. | 4.68e-05 | 3 | 138 | 2 | 10558865 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 25914748 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 15778383 | ||
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 18178577 | ||
| Pubmed | Tear lipocalin, lysozyme and lactoferrin concentrations in postmenopausal women. | 4.68e-05 | 3 | 138 | 2 | 26366224 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 33373444 | ||
| Pubmed | A novel isoform of myosin 18A (Myo18Aγ) is an essential sarcomeric protein in mouse heart. | 4.68e-05 | 3 | 138 | 2 | 30737279 | |
| Pubmed | GBP3 promotes glioblastoma resistance to temozolomide by enhancing DNA damage repair. | 4.68e-05 | 3 | 138 | 2 | 35780181 | |
| Pubmed | Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction. | 4.68e-05 | 3 | 138 | 2 | 12482844 | |
| Pubmed | KCNQ2 channels regulate the population activity of neonatal GABAergic neurons ex vivo. | 4.68e-05 | 3 | 138 | 2 | 37409016 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 20679227 | ||
| Pubmed | GBP3 promotes glioma cell proliferation via SQSTM1/p62-ERK1/2 axis. | 4.68e-05 | 3 | 138 | 2 | 29128363 | |
| Pubmed | RNA sensing by conventional dendritic cells is central to the development of lupus nephritis. | 4.68e-05 | 3 | 138 | 2 | 26512111 | |
| Pubmed | 4.68e-05 | 3 | 138 | 2 | 31444273 | ||
| Pubmed | Comparative human/murine sequence analysis of the common eliminated region 1 from human 3p21.3. | 4.77e-05 | 18 | 138 | 3 | 12461651 | |
| Pubmed | 5.34e-05 | 101 | 138 | 5 | 9872452 | ||
| Pubmed | ATP6AP1 SYNE1 ARHGAP26 KIF1B SPTBN1 MYO18A NCL BCAS1 YWHAH ASAP1 THBS4 ZC2HC1A SACS KCNQ2 MACF1 LYZ TRAPPC9 | 5.51e-05 | 1431 | 138 | 17 | 37142655 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | PDE4C UBE4B POLR2A KIF1B SPTBN1 MYO18A NCL SYAP1 BAZ2A KIAA1958 ESPL1 ARHGEF6 | 6.41e-05 | 774 | 138 | 12 | 15302935 |
| Pubmed | 6.64e-05 | 339 | 138 | 8 | 30415952 | ||
| Pubmed | TDRD15 EXOSC10 LIN54 KIF1B NCL NDRG3 GTF3C3 CD5 GCC2 SYDE2 ZFHX3 SMAP2 | 6.65e-05 | 777 | 138 | 12 | 35844135 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 6.96e-05 | 440 | 138 | 9 | 34244565 | |
| Pubmed | 7.71e-05 | 21 | 138 | 3 | 30007418 | ||
| Pubmed | ATP6AP1 OFD1 ZFYVE16 POLR2A SPTBN1 KPNA6 RB1CC1 YWHAH ASAP1 PPP2R5A TOX4 CCDC138 GNB4 HERC2 | 7.78e-05 | 1049 | 138 | 14 | 27880917 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 37059107 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 23343834 | ||
| Pubmed | Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. | 9.33e-05 | 4 | 138 | 2 | 9727055 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 32780724 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 16525039 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 30405132 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 27090492 | ||
| Pubmed | Regulation of autophagosome biogenesis by OFD1-mediated selective autophagy. | 9.33e-05 | 4 | 138 | 2 | 33368531 | |
| Pubmed | Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. | 9.33e-05 | 4 | 138 | 2 | 6338048 | |
| Pubmed | Macrophages Are Dispensable for Postnatal Pruning of the Cochlear Ribbon Synapses. | 9.33e-05 | 4 | 138 | 2 | 34744631 | |
| Pubmed | Protein ligands to HuR modulate its interaction with target mRNAs in vivo. | 9.33e-05 | 4 | 138 | 2 | 11018049 | |
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 34470858 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 32231671 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 37074204 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 29106904 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 32186932 | ||
| Pubmed | 9.33e-05 | 4 | 138 | 2 | 18439902 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 EXOSC10 ZFYVE16 SMCHD1 AHCTF1 POLR2A NCL SYAP1 TOX4 BAZ2A MASTL MACF1 PRR14L | 9.35e-05 | 934 | 138 | 13 | 33916271 |
| Pubmed | KDM5B SPAG1 ARHGAP26 YWHAH CCDC7 GMNC PPP2R5A GCC2 KRT20 GNB4 PYGO1 | 9.71e-05 | 686 | 138 | 11 | 29987050 | |
| Pubmed | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. | 1.13e-04 | 189 | 138 | 6 | 29449217 | |
| Pubmed | Hierarchical organization of cortical and thalamic connectivity. | 1.16e-04 | 24 | 138 | 3 | 31666704 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 1.24e-04 | 475 | 138 | 9 | 31040226 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 1.37e-04 | 281 | 138 | 7 | 28706196 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.43e-04 | 283 | 138 | 7 | 30585729 | |
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 30622267 | ||
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 22124266 | ||
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 25254654 | ||
| Pubmed | Disruption of 14-3-3 binding does not impair Protein 4.1B growth suppression. | 1.55e-04 | 5 | 138 | 2 | 15116094 | |
| Pubmed | A deficiency in the autophagy gene Atg16L1 enhances resistance to enteric bacterial infection. | 1.55e-04 | 5 | 138 | 2 | 23954160 | |
| Pubmed | 1.55e-04 | 5 | 138 | 2 | 21636789 | ||
| Pubmed | The Anp32 family of proteins containing leucine-rich repeats. | 1.55e-04 | 5 | 138 | 2 | 15895553 | |
| Pubmed | Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock. | 1.55e-04 | 5 | 138 | 2 | 11565755 | |
| Pubmed | 1.59e-04 | 68 | 138 | 4 | 14676191 | ||
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.56e-05 | 206 | 90 | 7 | 682 | |
| GeneFamily | ANP32 acidic nuclear phosphoproteins | 2.43e-04 | 5 | 90 | 2 | 27 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.27e-04 | 66 | 90 | 4 | 722 | |
| GeneFamily | Paraneoplastic Ma antigens | 1.31e-03 | 11 | 90 | 2 | 671 | |
| Coexpression | GSE3982_MAST_CELL_VS_BASOPHIL_DN | ZFYVE16 SYNE1 POLR2A SPTBN1 RB1CC1 PPP2R5A P2RY10 MACF1 SMPD3 | 1.15e-06 | 199 | 138 | 9 | M5439 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EHBP1 KDM5B DPYD ZFYVE16 CYTH1 SMCHD1 AHCTF1 RB1CC1 HIRA ADGRG6 THBS2 PPP2R5A SACS GCC2 MACF1 ZFHX3 MTCL1 | 2.78e-06 | 856 | 138 | 17 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 6.35e-06 | 86 | 138 | 6 | M39248 | |
| Coexpression | GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP | 1.14e-05 | 200 | 138 | 8 | M5168 | |
| Coexpression | KAMIKUBO_MYELOID_CEBPA_NETWORK | 1.81e-05 | 30 | 138 | 4 | M2092 | |
| Coexpression | KAMIKUBO_MYELOID_CEBPA_NETWORK | 2.07e-05 | 31 | 138 | 4 | MM883 | |
| Coexpression | FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN | STAC3 DGKG KPNA6 MAP3K6 SLC6A8 NLN BAZ2A SYDE2 TLE6 KCNQ2 ZFHX3 MTCL1 LTF COG4 | 4.12e-05 | 746 | 138 | 14 | M40863 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HOMTN | 4.24e-05 | 389 | 138 | 10 | M39073 | |
| Coexpression | GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP | 6.86e-05 | 190 | 138 | 7 | M4674 | |
| Coexpression | GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 8.60e-05 | 197 | 138 | 7 | M5347 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 8.60e-05 | 197 | 138 | 7 | M3193 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | OFD1 RASGRF2 UBE4B ANP32B SYNE1 AHCTF1 SPTBN1 NDRG3 RNF157 CCDC7 CD5 SACS GNPDA2 P2RY10 MACF1 HECTD1 | 8.81e-05 | 1012 | 138 | 16 | M40864 |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN | 8.88e-05 | 198 | 138 | 7 | M4603 | |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 8.92e-05 | 137 | 138 | 6 | M39241 | |
| Coexpression | GSE11924_TFH_VS_TH17_CD4_TCELL_UP | 9.16e-05 | 199 | 138 | 7 | M3156 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN | 9.45e-05 | 200 | 138 | 7 | M9352 | |
| Coexpression | GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN | 9.45e-05 | 200 | 138 | 7 | M7807 | |
| Coexpression | GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN | 9.45e-05 | 200 | 138 | 7 | M5689 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 1.01e-04 | 140 | 138 | 6 | M617 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 1.27e-04 | 146 | 138 | 6 | MM964 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.87e-09 | 191 | 138 | 9 | d4f77c73311d1149466bbfe4adbd6a301946ec90 | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.32e-08 | 200 | 138 | 9 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)-myeloid-myeloid_granulocytic|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.63e-07 | 193 | 138 | 8 | e1855cff9a6bcfda9188b9fdf6c9d698405da990 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.99e-07 | 198 | 138 | 8 | 3bc05b8d97a7219af40db7a11aa271f02e74fca5 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-07 | 199 | 138 | 8 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.06e-07 | 199 | 138 | 8 | b7af2b4fe6866cc8c78cf0f78390aab1b1b389ba | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.06e-07 | 199 | 138 | 8 | caf2e050b21e7a16ce4e51b3f135debd06810231 | |
| ToppCell | severe|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.15e-07 | 200 | 138 | 8 | accc618d6b960bff30cb531c1226295bfc8650f6 | |
| ToppCell | severe-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.15e-07 | 200 | 138 | 8 | 5ee43386da8261d2e7602a152e6ba4338d844e08 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-06 | 182 | 138 | 7 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.10e-06 | 189 | 138 | 7 | 3b35022c0619df6db234613aa53a076899ca9562 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.10e-06 | 189 | 138 | 7 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.18e-06 | 190 | 138 | 7 | 896b5825edb30fe62cbbed6078570c1f8057a99e | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.18e-06 | 190 | 138 | 7 | 38e83337c70c8734b63f8589ba59e0f98603f94c | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.34e-06 | 192 | 138 | 7 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.34e-06 | 192 | 138 | 7 | 9f12b79d661ef0f57c2c924e8ecc24a46ea996d2 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-06 | 192 | 138 | 7 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.42e-06 | 193 | 138 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.77e-06 | 197 | 138 | 7 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.77e-06 | 197 | 138 | 7 | 9599319dd1f80c81356a8624131566cc76d77d7e | |
| ToppCell | COVID-19_Severe-Neu_2|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 2.77e-06 | 197 | 138 | 7 | 945f19475905cdedf232315eea1076ca0b753b67 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-06 | 198 | 138 | 7 | 82f6ac18c3a6487f03579b5c247844f1c115c2be | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.86e-06 | 198 | 138 | 7 | f870e398e996c1f28c8462d87b18f71b20c71011 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 2.86e-06 | 198 | 138 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.96e-06 | 199 | 138 | 7 | 5919933c4b842b98fc98685dc8c72c8dd32c6ea3 | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.96e-06 | 199 | 138 | 7 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 3.06e-06 | 200 | 138 | 7 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.06e-06 | 200 | 138 | 7 | 808571d74bb5c4d765ff13fc9393f88020d4e90d | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-06 | 153 | 138 | 6 | cb144b8c487286384b47fdff88ff98fcf0508899 | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.19e-05 | 163 | 138 | 6 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-05 | 164 | 138 | 6 | fed26f4ac36a2b0722bc7b9f91659c5e0cf4d53a | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-05 | 165 | 138 | 6 | 9acf03b5a20170721380045b5c268825e8f315dd | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.62e-05 | 172 | 138 | 6 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD4_rest|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.79e-05 | 175 | 138 | 6 | 8269721389a3ce98681460e6393f2cff816eaa25 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.05e-05 | 52 | 138 | 4 | d654e2b77c53ed5319015598b68a20bf4416380c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-05 | 180 | 138 | 6 | 162cec1734e560c068cd61717e40e18dcf92308c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.09e-05 | 180 | 138 | 6 | 33c86c22ba877358cd8c1e39b5c0b3dc3a45b7dd | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 181 | 138 | 6 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-05 | 181 | 138 | 6 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | ASK454-Epithelial|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.23e-05 | 182 | 138 | 6 | ab15316cff989b61ff397a866d7ca8b49c13e981 | |
| ToppCell | Mild-CD4+_T|Mild / Disease group and Cell class | 2.44e-05 | 185 | 138 | 6 | c28ecb63146de1b02418e5a4fad0ae7c2b66a41d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 185 | 138 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.59e-05 | 187 | 138 | 6 | 4e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 188 | 138 | 6 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 188 | 138 | 6 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 189 | 138 | 6 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | cellseq-Immune-Hematopoietic-Granulocytic-Neutrophil|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.75e-05 | 189 | 138 | 6 | fedab592be1d6520325b8c1b659b0a4dc3f4fe4d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.75e-05 | 189 | 138 | 6 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 2.75e-05 | 189 | 138 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.75e-05 | 189 | 138 | 6 | 94dd5d4d815449feff7ce157fe7f8234f7c81422 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Treg|normal_Pleural_Fluid / Location, Cell class and cell subclass | 2.84e-05 | 190 | 138 | 6 | 632b9541371483d25948b6f033863c49f38e3603 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.92e-05 | 191 | 138 | 6 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.92e-05 | 191 | 138 | 6 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.92e-05 | 191 | 138 | 6 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 2.92e-05 | 191 | 138 | 6 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.92e-05 | 191 | 138 | 6 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.10e-05 | 193 | 138 | 6 | 58e1930a1d80ad3729ab9604ac8ebf7308232a3d | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.10e-05 | 193 | 138 | 6 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-05 | 194 | 138 | 6 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.19e-05 | 194 | 138 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.28e-05 | 195 | 138 | 6 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.28e-05 | 195 | 138 | 6 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-05 | 195 | 138 | 6 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.28e-05 | 195 | 138 | 6 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.28e-05 | 195 | 138 | 6 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.38e-05 | 196 | 138 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | COVID-19_Severe-Neu_2|World / 5 Neutrophil clusters in COVID-19 patients | 3.38e-05 | 196 | 138 | 6 | 16359a56297f0558fc93fa52563cce0c53def167 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.38e-05 | 196 | 138 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COVID-19-kidney-Macrophages|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.47e-05 | 197 | 138 | 6 | 3912301018d0863144dcfac8d1fa8adc081748d7 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Naive_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.47e-05 | 197 | 138 | 6 | cf72160f03105876641fa6fdc7405e339eb084c7 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.47e-05 | 197 | 138 | 6 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 3.47e-05 | 197 | 138 | 6 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.47e-05 | 197 | 138 | 6 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | COVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class | 3.47e-05 | 197 | 138 | 6 | 344801997b89bd81d8d5c3c872934de523233a8d | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.57e-05 | 198 | 138 | 6 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.57e-05 | 198 | 138 | 6 | 5024d43b4cf7dea305ed911f1e123ca7fd44e990 | |
| ToppCell | COVID-19_Severe-Neu_1|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 3.57e-05 | 198 | 138 | 6 | bbe639ea5a636c985e509fb0a133ae3b60afac5a | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.57e-05 | 198 | 138 | 6 | df546a9afc0e15398f33c1b511c7281771f9aea0 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.57e-05 | 198 | 138 | 6 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 3.57e-05 | 198 | 138 | 6 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.57e-05 | 198 | 138 | 6 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 3.67e-05 | 199 | 138 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | COVID-19_Severe-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 3.67e-05 | 199 | 138 | 6 | e4d8bf016fd95a440e30014a75587e097e90cfad | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.78e-05 | 200 | 138 | 6 | 6beabd5bad042d4d65c89c2f537c7376230f7c08 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-Treg|COVID-19_Mild / Disease, condition lineage and cell class | 3.78e-05 | 200 | 138 | 6 | c6ae15f7deba26008af5b647855675003bb2ebcd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.78e-05 | 200 | 138 | 6 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 3.78e-05 | 200 | 138 | 6 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.78e-05 | 200 | 138 | 6 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.78e-05 | 200 | 138 | 6 | 026495aa7f1e7528a01d9199475cfc393677fc60 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD4+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 3.78e-05 | 200 | 138 | 6 | deeed668b129e66156b5f6abe1a07a9bf842a14d | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.82e-05 | 148 | 138 | 5 | f58804d24fe524b42b5090c8658050ea4b14793e | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-neutrophil|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 150 | 138 | 5 | 6e806a028c0519489151c181d9907e05289e27e0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related-Oligodendrocyte/OPC|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 151 | 138 | 5 | 4533bccc996395f74b16af939ce79b6fe253c073 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-OPC_related|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 151 | 138 | 5 | edb2f59789c295838d2030b80c792cbea25eaa3d | |
| ToppCell | 18-Airway-Epithelial-Goblet-like_secretory|Airway / Age, Tissue, Lineage and Cell class | 1.15e-04 | 153 | 138 | 5 | 14a60220e169ce642771636de982a7b02e5b2608 | |
| ToppCell | tumor_Lymph_Node_/_Brain-B_lymphocytes-Undetermined|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 1.18e-04 | 154 | 138 | 5 | e16f200391537aa1002b0079481b94e1fb86b9ad | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-04 | 155 | 138 | 5 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-04 | 156 | 138 | 5 | d9d87368e43b24952e70f31f38425e15b716ff5b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 157 | 138 | 5 | 0673c7161c25feceee8f1e5fd237171576c42c6b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 157 | 138 | 5 | d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0 | |
| Disease | atrial fibrillation | 4.65e-05 | 371 | 132 | 9 | EFO_0000275 | |
| Disease | alkaline phosphatase measurement | TDRD15 PDE4C SPTBN1 BCAS1 SYAP1 GCC2 MACF1 PRR14L RP1 LTF LYZ COG4 PMFBP1 SENP7 | 1.88e-04 | 1015 | 132 | 14 | EFO_0004533 |
| Disease | 3-hydroxy-1-methylpropylmercapturic acid measurement | 1.93e-04 | 352 | 132 | 8 | EFO_0007015 | |
| Disease | intellectual disability (is_implicated_in) | 3.25e-04 | 30 | 132 | 3 | DOID:1059 (is_implicated_in) | |
| Disease | hippocampus fimbria volume | 4.11e-04 | 7 | 132 | 2 | EFO_0009402 | |
| Disease | mean platelet volume | POLR2A KIF1B SPTBN1 NAB1 CASR BCAS1 ASAP1 FRY TOX4 BAZ2A GCC2 ESPL1 SMAP2 | 6.76e-04 | 1020 | 132 | 13 | EFO_0004584 |
| Disease | cerebrospinal fluid biomarker measurement | 9.25e-04 | 96 | 132 | 4 | EFO_0006794 | |
| Disease | candidiasis (implicated_via_orthology) | 1.01e-03 | 44 | 132 | 3 | DOID:1508 (implicated_via_orthology) | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 1.06e-03 | 11 | 132 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Semantic-Pragmatic Disorder | 1.06e-03 | 11 | 132 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 1.06e-03 | 11 | 132 | 2 | C0751257 | |
| Disease | Language Delay | 1.06e-03 | 11 | 132 | 2 | C0023012 | |
| Disease | Language Development Disorders | 1.06e-03 | 11 | 132 | 2 | C0023014 | |
| Disease | Speech Delay | 1.06e-03 | 11 | 132 | 2 | C0241210 | |
| Disease | Primary Ciliary Dyskinesia | 1.23e-03 | 47 | 132 | 3 | C4551720 | |
| Disease | metabolite measurement, body weight gain | 1.27e-03 | 12 | 132 | 2 | EFO_0004566, EFO_0004725 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.30e-03 | 364 | 132 | 7 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | male infertility (implicated_via_orthology) | 1.50e-03 | 13 | 132 | 2 | DOID:12336 (implicated_via_orthology) | |
| Disease | pallidum volume change measurement | 1.50e-03 | 13 | 132 | 2 | EFO_0021494 | |
| Disease | body fat percentage | 1.63e-03 | 488 | 132 | 8 | EFO_0007800 | |
| Disease | factor VIII measurement, coronary artery disease | 1.69e-03 | 113 | 132 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 1.84e-03 | 194 | 132 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | Obesity | 2.34e-03 | 205 | 132 | 5 | C0028754 | |
| Disease | disease progression measurement | 2.61e-03 | 61 | 132 | 3 | EFO_0008336 | |
| Disease | Tinnitus | 2.81e-03 | 130 | 132 | 4 | HP_0000360 | |
| Disease | Ulcerative Colitis | 2.86e-03 | 63 | 132 | 3 | C0009324 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 3.26e-03 | 66 | 132 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | MYELODYSPLASTIC SYNDROME | 3.40e-03 | 67 | 132 | 3 | C3463824 | |
| Disease | polymyositis | 3.58e-03 | 20 | 132 | 2 | EFO_0003063 | |
| Disease | haptoglobin measurement | 3.94e-03 | 21 | 132 | 2 | EFO_0004640 | |
| Disease | Intellectual Disability | 4.07e-03 | 447 | 132 | 7 | C3714756 | |
| Disease | body weight | EHBP1 DPYD NEXMIF CYTH1 SMCHD1 RIPK2 DGKG ADGRG6 TOX4 ZC2HC1A ZFHX3 SMPD3 COG4 | 4.36e-03 | 1261 | 132 | 13 | EFO_0004338 |
| Disease | hemorrhoid | 4.36e-03 | 147 | 132 | 4 | EFO_0009552 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDCAVSENFQEFLSL | 536 | O14727 | |
| EQCDKYDAQALSAQL | 26 | O00421 | |
| QTEADCINNINDFLK | 61 | Q15052 | |
| CSQFAAQLEEALKEE | 136 | Q96M83 | |
| EQACLLAKQAFDDAI | 191 | Q04917 | |
| QAQAKFDSCLSDLAA | 581 | Q9H9E3 | |
| DISNCLKEANEVANQ | 576 | Q86SQ4 | |
| DALLVFDNCQTFNED | 1861 | Q9UIF9 | |
| AQNKIDSLNLDEFCN | 116 | P41180 | |
| NDCANKENIVNSFTD | 501 | Q96GX5 | |
| DKTQDLENFLCNNLQ | 191 | P06127 | |
| FFNSSVEDLLDNKCL | 1086 | Q86UQ4 | |
| LDDFFKSAVENCQDS | 391 | P52209 | |
| DKNCFNCEKLENNFD | 46 | Q12882 | |
| KSLDLFNCEVTNLND | 116 | P39687 | |
| KSLDLFNCEVTNLND | 116 | Q92688 | |
| DQELANAQTCLDQKG | 51 | Q05D60 | |
| KQCNFSDRQAELNID | 16 | Q9GZS0 | |
| KNNCNVDLAFDTLAD | 161 | Q8N4Z0 | |
| DSADLRCQLQFAKEE | 501 | Q9Y4B5 | |
| QNDFEKACQAKSEAL | 246 | O75665 | |
| NFLAANDQELDCDIL | 331 | P05546 | |
| AFNALKELVQECNAS | 546 | Q8IW93 | |
| CLEEVLQNKDNEFAL | 901 | Q8TDY2 | |
| LNDKNGTRNFQDFDC | 16 | Q9UGV2 | |
| EFLKRNENCTLQFEA | 131 | O60684 | |
| DFREENLKTANCTLA | 471 | P16389 | |
| ATCNCLLAQAEQADK | 696 | Q6MZP7 | |
| ALLQDNIADAVACAK | 101 | P61626 | |
| VNEAAAQLCVKDNAL | 276 | Q13506 | |
| ADNNIQDHNVKDFLC | 1396 | O95714 | |
| LACAVQELQDAKEAA | 926 | Q9BQS8 | |
| DNNDKSDCLAIKEQF | 536 | Q9UN88 | |
| QLCEELFEKINDNCN | 121 | O60333 | |
| DFNLITDDCFANSKK | 1626 | Q8IYD8 | |
| NCRNNTDLFEKGNAD | 591 | Q8IVV2 | |
| KNNCDQDDASASACL | 411 | Q8NDZ0 | |
| ILVADNFDKNLCFSE | 5001 | Q5CZC0 | |
| LQALREDVFQKNSDC | 156 | O95382 | |
| KENLDALNSCYAAVA | 811 | O43526 | |
| AQLKNQLEESEFTCA | 1686 | Q92614 | |
| AENCDIFQNLSAKQR | 471 | Q08493 | |
| FANSNDKDDQVLNCH | 171 | Q96E22 | |
| ENDLLKNTCEDIAQF | 86 | Q15438 | |
| DLAAYNAALSCNEND | 236 | P50458 | |
| LQNEEASAKYCQAEL | 411 | Q96PP9 | |
| NQIQDARKACNDATL | 16 | Q9HAV0 | |
| LQNEEASAKYCQAEL | 396 | Q8N8V2 | |
| DAEKCASVAQQLLNG | 806 | Q9UGL1 | |
| NECVALLDKAATAQN | 111 | Q8N8V4 | |
| FNFDNCSSDDKLEQQ | 511 | Q9NY59 | |
| CVLQIDNAKLAAEDF | 141 | P35900 | |
| QAESNKAFLAELEQN | 4506 | Q9UPN3 | |
| FDALGSQACSNKNLE | 5041 | Q9UPN3 | |
| ASFEDAKEALNSCNK | 531 | P19338 | |
| KNAQLLAFENDDCHL | 21 | P25929 | |
| ANKQNCFDDFQCAAE | 521 | P48147 | |
| AESDKFCALSAEQQD | 146 | O75344 | |
| NIQNADNATKADEAC | 106 | P49619 | |
| DNATIELFFLNAKSC | 111 | Q9P2Q2 | |
| NEKLLNCQEFAVDLE | 301 | Q01780 | |
| DNSALNCHSNDDKNA | 1121 | Q9ULT8 | |
| NLAADAAQSKCLDQA | 736 | Q14674 | |
| LQCETAAQQKFAEEL | 191 | Q96M89 | |
| GNNCLDAAKACNLDD | 151 | P56159 | |
| SNSGNDLEECLKFLN | 316 | P56159 | |
| DCDLRASQAALFEKN | 401 | Q96A19 | |
| ECELENLRKATSNAN | 296 | Q8IWJ2 | |
| NSQDCGQKRQLFDSD | 876 | A2RUB6 | |
| ATDLNDKSVQCALDF | 36 | P28325 | |
| DFLVQNCGNLDKQTA | 621 | Q9ULH1 | |
| KCLNVNLTEEDFNEA | 786 | Q8IY85 | |
| NLTEEDFNEALNCCN | 791 | Q8IY85 | |
| QLNALSSLDEDQDDC | 216 | Q8NDI1 | |
| AADLQAECDAFENKI | 111 | Q8TDQ7 | |
| GECLLANQEIDKFQS | 341 | P10911 | |
| LQEACDQANLSLDDK | 586 | Q8N7U6 | |
| NFDTIDQQFCDLADN | 1556 | Q8WYP5 | |
| DQQFCDLADNKDTAE | 1561 | Q8WYP5 | |
| EAAVDNLSDCLKNSD | 1916 | Q5TBA9 | |
| VALDKASLQFAECQD | 811 | Q5M9N0 | |
| LVSDKQDSLAQCADF | 856 | P54198 | |
| DCDQSQTARDLKLDF | 926 | A2RUR9 | |
| AKDDSQAAAIAENNN | 271 | O75363 | |
| ENLFEALNNKNCQAL | 106 | P31944 | |
| ALNESLAQDKLDLNC | 46 | Q86T23 | |
| DIFKELLQNADDANA | 1476 | Q9NZJ4 | |
| LLQNADDANATECSF | 1481 | Q9NZJ4 | |
| QNADDAKATEICFVF | 2551 | Q9NZJ4 | |
| RSTDLNNNKSCFADL | 171 | O00398 | |
| QLNEASCNDFLFERK | 556 | Q5THK1 | |
| SLDDFENCSLRKFQD | 1416 | P56715 | |
| LAAQQAAQCKEEAAL | 481 | Q8TBY8 | |
| NDDQDAILCEASCQK | 351 | Q9Y3Y4 | |
| SKNCALDFNEENDAD | 351 | Q5VT97 | |
| DANLCDANKVQSDSL | 121 | Q9BQF6 | |
| FEQRSSLECAQKAAE | 251 | Q96KN7 | |
| DNNNDFDIASVKALD | 616 | Q96PX1 | |
| ANAETFSCNKIKDND | 1426 | A6NHR9 | |
| FFASSLEAVKQNLDC | 16 | A8MYB1 | |
| ETKNLLFNDNTECLA | 656 | P02788 | |
| DKQALQDCASELGSF | 2506 | Q8NF91 | |
| ENSKNISFECLFADL | 1646 | B5MCY1 | |
| AKRNLSSEFANCEEQ | 166 | A6NCL1 | |
| SLQVLANCKQNRDFD | 346 | O14827 | |
| LDKCNTEEALLANSN | 241 | Q5QGS0 | |
| ADSLNEFKFQCIGDA | 61 | Q9UNA1 | |
| LEENQNALKFCNLAL | 371 | Q96LZ7 | |
| VSDAFDACNLNQEDL | 276 | Q96A49 | |
| ANASLANLTCDQLAD | 191 | P48029 | |
| FEKNCGNDNICQDDL | 766 | P11215 | |
| AQDCLAALAQVFGDN | 221 | P0CW24 | |
| LFDANKAELFTQSCA | 1376 | Q01082 | |
| DQESANCDAKAIFAV | 601 | Q9Y5Q9 | |
| DATSNEQQELFCQKL | 61 | Q15172 | |
| DFNTDNFICKEDLEL | 116 | O75838 | |
| SELCIDFNKNLNEDD | 196 | Q9BYT8 | |
| DACDNCLSVLNNDQK | 541 | P35443 | |
| DATFQRLLDDNFCNK | 226 | Q9Y5K1 | |
| LANLLLEEDNKFCAD | 16 | Q8WU79 | |
| ANLDQLNDGQDFAKD | 436 | Q9BQI7 | |
| ENFLLTKCNGSIADN | 211 | Q96IC2 | |
| APQDNDFLSRKAQDC | 366 | O43353 | |
| DDLNCIFNDDNAEKL | 1241 | P24928 | |
| QLDCARFAKAIADDQ | 1161 | O95155 | |
| ADFIKQECLNNIGDA | 86 | O14787 | |
| AKQDCDQALQLADGN | 676 | Q07617 | |
| NEAFDFAKNLCSLQL | 351 | Q92753 | |
| CSDAATNKNFNRLQD | 291 | O75326 | |
| NKQDSAFSNLENALD | 111 | Q15904 | |
| NDDNCQVFIKFLSEL | 231 | Q9Y2C9 | |
| AGCAADQAKQLLQAA | 21 | Q8IYN6 | |
| ENAADRHINFCKEQA | 131 | Q96GY0 | |
| FLECLNNDTEESKQL | 511 | Q7Z3V4 | |
| TCDNESNKAQVFENL | 361 | P0CG32 | |
| LDFSCQENLLQDLSD | 796 | Q96Q05 | |
| NDGVTDEKDNCQLLF | 746 | P35442 | |
| QYACVKDLSAANRND | 161 | Q96MF2 | |
| ALAAYKDNQECQATV | 286 | O94842 | |
| NCQALDANLDANLAF | 381 | Q9H808 | |
| DLCLNDSNSRDENFK | 311 | Q7Z3T8 | |
| AGCAADQAKQLLQAA | 21 | Q8TB05 | |
| VNLNFDQTKLDNDDC | 2821 | Q15911 | |
| VFNINDDLNDLCTSA | 401 | Q8N8K9 |